NIH unit awards vaccine contract to Crucell

10/5/2008 | Boston Globe (tiered subscription model), The

Crucell announced that it secured a contract worth as much as $70 million from the National Institute of Allergy and Infectious Diseases to develop vaccines for the Ebola and Marburg viruses, which are responsible for hemorrhagic fever. The Dutch biotech firm said it will work with the Southwest Foundation for Biomedical Research in San Antonio and Quintiles Guy's Drug Research Unit in London for the project.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA